Rare diseases
Investigational molecules
Locations
Back to Spain155 clinical trials in Lugo, Spain across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)Long‑Term Safety and Efficacy of SPY001-001, SPY002 and SPY003 in Adults with Ulcerative Colitis
SpainA study to evaluate the safety and effectiveness of HLX43 in patients with advanced non-small cell lung cancer
SpainA Study of Long-acting Antibodies SPY001-001 and SPY002 Alone and Combined for Adults with Moderate to Severe Ulcerative Colitis
SpainStudy of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk
SpainStudy of Dostarlimab After Chemoradiation for Adults with Advanced Unresected Head and Neck Cancer
SpainStudy of ivonescimab plus enfortumab vedotin versus pembrolizumab plus enfortumab vedotin in previously untreated locally advanced or metastatic urothelial carcinoma
SpainRamantamig (JNJ-79635322) with drug combination versus standard therapy in newly diagnosed multiple myeloma patients not eligible for stem cell transplant
SpainStudy of Beclometasone Dipropionate in Patients with Asthma to Evaluate Disease Characteristics and Control
SpainTicagrelor, Acetylsalicylic Acid and Prasugrel in Patients with Acute Coronary Syndrome: A Study of Antiplatelet Management
SpainEfficacy and Safety of Depemokimab for Early Intervention in Adults and Adolescents with Type 2 Asthma at Risk of Exacerbations
SpainSensitivity and specificity of Lepidoglyphus destructor extract, sodium chloride and histamine dihydrochloride in skin prick test for Lepidoglyphus destructor allergy patients
SpainDurvalumab and Chemotherapy in Adults With Muscle-Invasive Bladder Cancer
SpainThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking research focusing on metastatic prostate cancer, breast cancer, and non-small cell lung cancer treatments. Studies evaluate innovative therapies including immunotherapy combinations and targeted treatments.
Multiple trials exploring both neoadjuvant and adjuvant treatment approaches to improve patient outcomes.
Clinical research examining treatments for advanced colon cancer, pancreatic adenocarcinoma, and urothelial cancer. Studies evaluate neoadjuvant chemotherapy effectiveness and novel drug combinations.
Focus on improving survival rates through optimized treatment sequences and combinations.
Innovative research in IgA nephropathy and related conditions. Studies evaluate new therapeutic agents and their combinations with existing treatments to improve patient outcomes.
Emphasis on developing targeted therapies for chronic kidney conditions and immune-mediated disorders.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
